Pro-Dex Inc

NASDAQ:PDEX USA Medical Instruments & Supplies
Market Cap
$157.00 Million
Market Cap Rank
#18885 Global
#6972 in USA
Share Price
$48.97
Change (1 day)
-2.06%
52-Week Range
$23.91 - $69.00
All Time High
$69.00
About

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory… Read more

Pro-Dex Inc (PDEX) - Net Assets

Latest net assets as of December 2025: $41.63 Million USD

Based on the latest financial reports, Pro-Dex Inc (PDEX) has net assets worth $41.63 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.26 Million) and total liabilities ($20.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $41.63 Million
% of Total Assets 66.87%
Annual Growth Rate 8.41%
5-Year Change 44.04%
10-Year Change 312.66%
Growth Volatility 94.69

Pro-Dex Inc - Net Assets Trend (1987–2025)

This chart illustrates how Pro-Dex Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Pro-Dex Inc (1987–2025)

The table below shows the annual net assets of Pro-Dex Inc from 1987 to 2025.

Year Net Assets Change
2025-06-30 $36.63 Million +18.68%
2024-06-30 $30.87 Million -2.29%
2023-06-30 $31.59 Million +24.22%
2022-06-30 $25.43 Million 0.00%
2021-06-30 $25.43 Million +33.41%
2020-06-30 $19.06 Million +12.08%
2019-06-30 $17.01 Million -1.55%
2018-06-30 $17.28 Million +26.01%
2017-06-30 $13.71 Million +54.44%
2016-06-30 $8.88 Million +4.71%
2015-06-30 $8.48 Million -8.01%
2014-06-30 $9.22 Million +16.11%
2013-06-30 $7.94 Million -16.89%
2012-06-30 $9.55 Million -7.50%
2011-06-30 $10.32 Million +35.57%
2010-06-30 $7.62 Million -27.35%
2009-06-30 $10.48 Million -21.18%
2008-06-30 $13.30 Million +3.48%
2007-06-30 $12.85 Million +6.44%
2006-06-30 $12.07 Million +8.64%
2005-06-30 $11.11 Million +28.27%
2004-06-30 $8.66 Million +16.42%
2003-06-30 $7.44 Million +1.69%
2002-06-30 $7.32 Million -17.27%
2001-06-30 $8.85 Million +49.17%
2000-06-30 $5.93 Million +40.32%
1999-06-30 $4.23 Million -67.89%
1998-06-30 $13.16 Million +2.81%
1997-06-30 $12.80 Million -26.44%
1996-06-30 $17.40 Million +346.15%
1995-06-30 $3.90 Million -2.50%
1994-06-30 $4.00 Million +33.33%
1993-06-30 $3.00 Million +7.14%
1992-06-30 $2.80 Million +64.71%
1991-06-30 $1.70 Million +240.00%
1990-06-30 $500.00K +400.00%
1989-06-30 $100.00K -80.00%
1988-06-30 $500.00K -70.59%
1987-06-30 $1.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to Pro-Dex Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 2894.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings $35.93 Million 98.08%
Common Stock $704.00K 1.92%
Total Equity $36.63 Million 100.00%

Pro-Dex Inc Competitors by Market Cap

The table below lists competitors of Pro-Dex Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pro-Dex Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 30,867,000 to 36,632,000, a change of 5,765,000 (18.7%).
  • Net income of 8,978,000 contributed positively to equity growth.
  • Share repurchases of 3,504,000 reduced equity.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $8.98 Million +24.51%
Share Repurchases $3.50 Million -9.57%
Other Changes $291.00K +0.79%
Total Change $- 18.68%

Book Value vs Market Value Analysis

This analysis compares Pro-Dex Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.49x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 8.35x to 4.49x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1987-06-30 $5.87 $48.97 x
1988-06-30 $1.29 $48.97 x
1989-06-30 $0.24 $48.97 x
1990-06-30 $0.90 $48.97 x
1991-06-30 $2.55 $48.97 x
1992-06-30 $2.24 $48.97 x
1993-06-30 $1.80 $48.97 x
1994-06-30 $2.40 $48.97 x
1995-06-30 $1.95 $48.97 x
1996-06-30 $6.17 $48.97 x
1997-06-30 $4.23 $48.97 x
1998-06-30 $4.42 $48.97 x
1999-06-30 $1.44 $48.97 x
2000-06-30 $1.99 $48.97 x
2001-06-30 $3.02 $48.97 x
2002-06-30 $2.50 $48.97 x
2003-06-30 $2.47 $48.97 x
2004-06-30 $2.79 $48.97 x
2005-06-30 $3.45 $48.97 x
2006-06-30 $3.63 $48.97 x
2007-06-30 $3.96 $48.97 x
2008-06-30 $4.02 $48.97 x
2009-06-30 $3.24 $48.97 x
2010-06-30 $2.36 $48.97 x
2011-06-30 $3.14 $48.97 x
2012-06-30 $2.92 $48.97 x
2013-06-30 $2.39 $48.97 x
2014-06-30 $2.64 $48.97 x
2015-06-30 $2.03 $48.97 x
2016-06-30 $2.13 $48.97 x
2017-06-30 $3.36 $48.97 x
2018-06-30 $3.98 $48.97 x
2019-06-30 $3.96 $48.97 x
2020-06-30 $4.67 $48.97 x
2021-06-30 $6.46 $48.97 x
2022-06-30 $6.76 $48.97 x
2023-06-30 $8.69 $48.97 x
2024-06-30 $8.64 $48.97 x
2025-06-30 $10.90 $48.97 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pro-Dex Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 24.51%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 13.48%
  • • Asset Turnover: 1.09x
  • • Equity Multiplier: 1.67x
  • Recent ROE (24.51%) is above the historical average (-17.13%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1987 -23.53% -14.29% 0.85x 1.94x $-570.00K
1988 -240.00% -44.44% 1.13x 4.80x $-1.25 Million
1989 -500.00% -25.00% 1.05x 19.00x $-510.00K
1990 60.00% 13.64% 1.00x 4.40x $250.00K
1991 11.76% 9.52% 0.84x 1.47x $30.00K
1992 10.71% 5.66% 1.33x 1.43x $20.00K
1993 3.33% 1.43% 1.49x 1.57x $-200.00K
1994 15.00% 7.41% 1.45x 1.40x $200.00K
1995 7.69% 3.33% 1.58x 1.46x $-90.00K
1996 6.90% 5.77% 0.73x 1.63x $-540.00K
1997 -12.50% -8.33% 0.79x 1.89x $-2.88 Million
1998 2.69% 1.56% 0.99x 1.74x $-962.42K
1999 -211.41% -48.71% 1.04x 4.19x $-9.36 Million
2000 25.99% 5.78% 1.62x 2.77x $948.00K
2001 32.18% 19.18% 1.26x 1.33x $1.96 Million
2002 -21.40% -14.88% 1.06x 1.36x $-2.30 Million
2003 1.79% 1.11% 1.32x 1.22x $-611.20K
2004 12.93% 7.89% 1.32x 1.25x $253.60K
2005 16.64% 13.37% 1.08x 1.15x $737.70K
2006 6.85% 4.85% 0.96x 1.47x $-380.30K
2007 3.94% 2.35% 1.19x 1.41x $-779.10K
2008 2.38% 1.26% 1.16x 1.63x $-1.01 Million
2009 -27.14% -13.47% 1.28x 1.57x $-3.89 Million
2010 -38.98% -12.79% 1.63x 1.88x $-3.73 Million
2011 25.57% 9.74% 1.74x 1.51x $1.61 Million
2012 -9.17% -5.08% 1.35x 1.34x $-1.83 Million
2013 -22.48% -14.56% 1.16x 1.33x $-2.58 Million
2014 -5.30% -4.51% 0.92x 1.27x $-1.41 Million
2015 -4.31% -2.73% 1.07x 1.48x $-1.21 Million
2016 9.26% 4.08% 1.81x 1.26x $-65.70K
2017 37.08% 23.17% 1.34x 1.19x $3.71 Million
2018 9.38% 7.22% 1.13x 1.15x $-106.60K
2019 24.39% 15.27% 1.06x 1.50x $2.45 Million
2020 32.06% 17.55% 1.12x 1.63x $4.21 Million
2021 17.98% 10.88% 0.86x 1.93x $2.03 Million
2022 17.98% 10.88% 0.86x 1.93x $2.03 Million
2023 22.39% 15.35% 0.89x 1.64x $3.92 Million
2024 6.89% 3.95% 1.03x 1.70x $-959.70K
2025 24.51% 13.48% 1.09x 1.67x $5.31 Million

Industry Comparison

This section compares Pro-Dex Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $771,083,081
  • Average return on equity (ROE) among peers: -146.50%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Pro-Dex Inc (PDEX) $41.63 Million -23.53% 0.50x $85.66 Million
ANGELALIGN TECHNOLOGY INC (AGLFF) $520.03 Million 8.62% 0.25x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $2.56 Billion 36.42% 1.05x $36.83 Billion
Align Technology Inc (ALGN) $161.15 Million 22.17% 0.38x $11.50 Billion
AngioDynamics Inc (ANGO) $372.19 Million 2.67% 0.10x $344.14 Million
Ansell Limited (ANSLF) $1.56 Billion 10.20% 0.61x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $7.93 Billion
AtriCure Inc (ATRC) $483.76 Million 10.38% 0.27x $1.38 Billion
Avinger Inc (AVGR) $4.24 Million -1323.46% 11.63x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $18.90 Million -243.53% 0.62x $156.14 Million